| Ajanta Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532331 |
NSE Symbol : AJANTPHARM |
P/E(TTM) : 48.15 |
|
ISIN Demat : INE031B01049 |
Div & Yield% : 1.61 |
EPS(TTM) : 66.55 |
|
Book Value(₹) : 273.25 |
Market Cap(₹Cr) : 40,029.33 |
Face Value(₹) : 2.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 3,971.12 | 3,411.27 | 3,140.64 | 2,718.59 | 2,196.42 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 3,971.12 | 3,411.27 | 3,140.64 | 2,718.59 | 2,196.42 |
| Other Income | 116.48 | 132.75 | 139.73 | 103.57 | 184.20 |
| Stock Adjustments | 22.17 | 21.99 | 56.60 | 74.60 | -9.02 |
| Total Income | 4,109.77 | 3,566.01 | 3,336.97 | 2,896.76 | 2,371.60 |
| EXPENDITURE : | |||||
| Raw Materials | 1,101.59 | 1,027.40 | 889.16 | 804.68 | 654.95 |
| Power and Fuel Cost | 66.44 | 65.53 | 54.09 | 43.42 | 38.56 |
| Other Manufacturing Expenses | 168.11 | 185.50 | 169.95 | 119.25 | 124.80 |
| Selling and Administration Expenses | 587.88 | 602.95 | 512.46 | 324.31 | 308.60 |
| Miscellaneous Expenses | 115.68 | 132.19 | 94.82 | 86.51 | 93.81 |
| Employee Benefit Expenses | 834.16 | 720.41 | 585.87 | 498.11 | 437.82 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,235.91 | 832.03 | 1,030.62 | 1,020.48 | 713.06 |
| Interest | 6.80 | 5.23 | 9.12 | 6.90 | 9.10 |
| Gross Profit | 1,229.11 | 826.80 | 1,021.50 | 1,013.58 | 703.96 |
| Depreciation | 132.16 | 126.95 | 120.96 | 111.49 | 91.29 |
| Profit Before Tax | 1,096.95 | 699.85 | 900.54 | 902.09 | 612.67 |
| Current Tax | 280.56 | 141.08 | 171.17 | 216.68 | 168.09 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 9.15 | 0.05 | 9.51 | 9.77 | 3.45 |
| Reported Net Profit | 807.24 | 558.72 | 719.86 | 675.64 | 441.13 |
| Extraordinary Items | 11.11 | 12.87 | -0.62 | 2.91 | -2.89 |
| Adjusted Net Profit | 796.13 | 545.85 | 720.48 | 672.73 | 444.02 |
| Adjustment below Net Profit | -0.92 | -74.72 | -68.50 | -32.42 | -3.85 |
| Profit/Loss Balance carried down | 3,089.29 | 2,694.98 | 2,125.83 | 1,565.51 | 1,244.15 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 642.17 | 89.69 | 82.21 | 82.90 | 115.93 |
| P & L Balance carried down | 3,253.44 | 3,089.29 | 2,694.98 | 2,125.83 | 1,565.50 |
| Dividend | 642.17 | 89.69 | 82.21 | 82.90 | 113.44 |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 2,550.00 | 350.00 | 475.00 | 475.00 | 650.00 |
| Dividend Per Share(Rs) | 51.00 | 7.00 | 9.50 | 9.50 | 13.00 |
| Earnings Per Share-Unit Curr | 63.89 | 44.22 | 83.85 | 77.70 | 50.30 |
| Earnings Per Share(Adj)-Unit Curr | 63.89 | 44.22 | 55.90 | 51.80 | 33.53 |
| Book Value | 270.17 | 256.94 | 369.15 | 331.80 | 280.65 |
| Book Value(Adj)-Unit Curr | 270.17 | 256.94 | 246.10 | 221.20 | 187.10 |